A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis
Clinical trial NCT03056989 · COMPLETED
Trial details
- NCT number
- NCT03056989
- Sponsor
- Spyryx Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2017-08-02
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.